Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1335 of 6351
-
New PARP1 inhibitor targets Hard-to-Treat cancers
Disease control Not yet recruitingThis is a Phase 1, open-label, multicenter study to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of HSK46256 tablets, a selective PARP1 inhibitor, in patients with advanced solid tumors. The study consists of a dose escalation phase and a do…
Phase 1 • Sponsor: Haisco Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Could a simple wrist grip ease anxiety during C-Section?
Symptom relief Recruiting nowThis randomized controlled trial will compare two upper-extremity restraint techniques in patients undergoing elective cesarean delivery under neuraxial anesthesia. Participants will be randomly assigned to either standard forearm restraint placement or wrist-level gripping restr…
Sponsor: Ohio State University • Aim: Symptom relief
Last updated Aug 21, 2026 00:00 UTC
-
Brain training without drugs: can imagining movement ease MS pain?
Symptom relief Not yet recruitingMany types of pain can occur in Multiple Sclerosis (MS), one of the most common types is neuropathic pain. Neuropathic pain is directly related to the disease's demyelination process and is associated with dysesthetic pain, allodynia, hyperalgesia. For neuropathic pain in MS, the…
Sponsor: Uludag University • Aim: Symptom relief
Last updated Jul 19, 2026 00:00 UTC
-
Could early surgery for a rare hormone disorder cause lifelong regret?
Knowledge-focused Recruiting nowCongenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency is a chronic endocrine disorder, often diagnosed in the neonatal period. Severe forms may lead to genital virilization in afected girls and adrenal crises. Management includes lifelong hormone replacement thera…
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Aug 26, 2026 00:00 UTC
-
One therapy to tackle two conditions: a trial combines exposure and habit reversal for tourettic OCD
Symptom relief Recruiting nowObsessive-Compulsive Disorder and Tic Disorders frequently co-occur, and a subgroup of patients - those with a Tourettic Subtype of OCD (TOCD) - present with concurrent obsessive-compulsive and tic symptoms. Existing psychological interventions typically target one condition or t…
Sponsor: University College London Hospitals • Aim: Symptom relief
Last updated Jul 29, 2026 00:00 UTC
-
Can a new PET tracer reveal the Body's immune battles?
Knowledge-focused Recruiting nowThis is an exploratory clinical study of copper-64 \[Cu-64\]-labeled granzyme B (GzmB)-targeted compounds for PET/CT imaging. The goal is to determine how GzmB-Targeted \[Cu-64\]-labeled compounds are distributed in the body by assessing PET/CT images and blood samples, and to as…
Early phase 1 • Sponsor: Ratio Therapeutics, Inc. • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
New hope for lung scarring? drug trial aims to slow breathing decline
Disease control Recruiting nowThe purpose of this study is to evaluate the efficacy, safety, and tolerability at Week 24 of 2 doses of CHF10067 (zampilimab) in participants with idiopathic pulmonary fibrosis (IPF). It is a phase IIb, multicentre, randomised, double-blind, placebo-controlled, three-arm parall…
Phase 2 • Sponsor: Chiesi Farmaceutici S.p.A. • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New drug IDP-001 takes on advanced cancers in early trial
Disease control Recruiting nowThis clinical study is to evaluate the safety, tolerability, pharmacokinetics (PK), and preliminary antitumor activity of IDP-001 in participants with advanced or metastatic squamous and non-squamous NSCLC and other squamous cell solid tumors (for example, head and neck, esophage…
Phase 1/2 • Sponsor: InduPro, Inc. • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Could a Head-Zap device ease fibromyalgia pain at home?
Symptom relief Recruiting nowThe purpose of this randomized controlled trial is to investigate the non-inferiority, and possible superiority, of a high-dose home-based tDCS protocol compared with a conventional home-based protocol, and to assess its cost-effectiveness, in patients with fibromyalgia. As comp…
Sponsor: Ionclinics & Deionic SL • Aim: Symptom relief
Last updated Jul 17, 2026 00:00 UTC
-
Brain training may help prevent alcohol relapse after withdrawal
Disease control Not yet recruitingTUA-VelCo is a single-center randomized controlled superiority trial with blinded methodological assessment. Adult patients hospitalized for alcohol withdrawal and meeting the criteria for Alcohol Use Disorder (AUD) according to the Diagnostic and Statistical Manual of Mental Dis…
Sponsor: Centre Hospitalier Esquirol • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Hormones may change how HIV prevention drug works in the body
Knowledge-focused Recruiting nowThis is a research study to better understand how long-acting cabotegravir (CAB-LA) works to prevent HIV in people. This study will also evaluate the impact of endogenous and therapeutic hormones on CAB-LA pharmacology. The investigators will also evaluate if participants experie…
Phase 1 • Sponsor: Johns Hopkins University • Aim: Knowledge-focused
Last updated Jul 15, 2026 00:00 UTC
-
Could stem cells restore erectile function after prostate surgery?
Disease control Recruiting nowThis is a phase 1/2 single center, pilot study to assess safety and efficacy of allogeneic adipose-derived mesenchymal stem cells (HB-adMSCs) and to evaluate the timing and combination effects of active treatment versus placebo in promoting the recovery of erectile function in pa…
Phase 1/2 • Sponsor: The Methodist Hospital Research Institute • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
New drug combo aims to shrink Hard-to-Treat cancers
Disease control Recruiting nowThe goal of this clinical trial is to learn if investigational agent LRK-4189 works to treat solid tumors in adults, with a focus on colorectal cancer. It will also learn about the safety of drug LRK-4189. The main questions it aims to answer are: Is LRK-4189, administered alon…
Phase 1/2 • Sponsor: LARKSPUR BIOSCIENCES, INC. • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Precision radiation trial aims to halt prostate cancer spread
Disease control Recruiting nowThis prospective, single-arm feasibility study will include patients with prostate cancer that have controlled local disease diagnosed with oligorecurrent para-aortic nodal disease and/or common iliac nodal disease detected by PSMA PET or conventional CT/MRI imaging, and these pa…
Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New pill aims to calm Flare-Ups in ulcerative colitis
Disease control Not yet recruitingThis is a Phase 2, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy, safety, and pharmacokinetics of IPG11406, an investigational oral drug, in adult patients with moderately to severely active ulcerative colitis (UC). UC is a chronic infl…
Phase 2 • Sponsor: Nanjing Immunophage Biotech Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
Heart clot detection gets a High-Tech upgrade: new PET scan tested in rare heart disease
Diagnosis Recruiting nowThe primary goal of this pilot study is to determine whether \[64Cu\]FBP8, a novel fibrin-binding positron emission tomography (PET) probe, can identify intracardiac thrombi when paired with simultaneous hybrid cardiac PET/MRI in twenty (20) individuals with transthyretin or ligh…
Phase 3 • Sponsor: Brigham and Women's Hospital • Aim: Diagnosis
Last updated Jul 23, 2026 00:00 UTC
-
Diabetes drug tirzepatide tested for type 1 in new trial
Disease control Recruiting nowThis study will examine the effects of Tirzepatide (TZP), a glucagon-like peptide 1 (GLP1) - gastric inhibitory peptide (GIP) co-agonist, on metabolism in type 1 diabetes (T1D). Research participants with T1D will undergo measures of insulin sensitivity, and hormone levels post-m…
Phase 2 • Sponsor: Victor Chang Cardiac Research Institute • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Your genes may decide your new Liver's fate after MASH transplant
Knowledge-focused Recruiting nowMASH (Metabolic Dysfunction-associated Steatohepatitis) is among the most common indications for liver transplantation.The metabolic syndrome persists after liver transplant and is often further exacerbated among MAFLD patients, thereby leading to recurrence of MAFLD in the allog…
Sponsor: Institute of Liver and Biliary Sciences, India • Aim: Knowledge-focused
Last updated Jul 23, 2026 00:00 UTC
-
Can a computer program teach teens to drink less?
Disease control Recruiting nowThis 8-week clinical trial will test a computer-based skills training program called Path180 with 112 adolescents aged 13 to 19 who are receiving mental health counseling or outpatient substance use treatment. Participants will be randomly assigned to either standard treatment (t…
Sponsor: Brown University • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Can a new drug help sepsis patients with weak immune systems?
Disease control Not yet recruitingThis is a Phase 2, randomized, open-label study evaluating the safety and efficacy of nogapendekin alfa inbakicept (NAI, ANKTIVA®) in combination with standard of care versus standard of care alone in critically ill adults with sepsis and persistent lymphopenia. The study aims to…
Phase 2 • Sponsor: ImmunityBio, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC